BIOERG SPÓLKA AKCYJNA |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1355 PLN | -5.57% |
|
-.--% | -.--% |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 13.22 | 9.152 | 8.033 | 27.45 | 11.95 | 18.2 |
| Enterprise Value (EV) 1 | 12.9 | 8.595 | 7.839 | 26.85 | 11.72 | 17.88 |
| P/E ratio | -348 x | -12.5 x | -155 x | -2.25 x | 59.5 x | -276 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | 1,132,344 x | 491,530 x | 2,690,067 x | 6,314,975 x | 60,874,689 x |
| EV / Revenue | - | 1,063,426 x | 479,660 x | 2,630,788 x | 6,193,939 x | 59,791,077 x |
| EV / EBITDA | -250 x | -28.3 x | -42.4 x | 135 x | -43.9 x | -483 x |
| EV / FCF | -147 x | 9.32 x | -9.25 x | 107,399 x | -11.3 x | -705 x |
| FCF Yield | -0.68% | 10.7% | -10.8% | 0% | -8.82% | -0.14% |
| Price to Book | 1.01 x | 0.74 x | 0.65 x | 305 x | 41.1 x | 80.9 x |
| Nbr of stocks (in thousands) | 101,685 | 101,685 | 101,685 | 101,685 | 101,685 | 101,685 |
| Reference price 2 | 0.1300 | 0.0900 | 0.0790 | 0.2700 | 0.1175 | 0.1790 |
| Announcement Date | 3/21/18 | 3/21/19 | 3/20/20 | 3/19/21 | 3/21/22 | 3/20/23 |
1PLN in Million2PLN
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales | - | 8.082 | 16.34 | 10.21 | 1.892 | 0.299 |
| EBITDA 1 | -0.0517 | -0.304 | -0.185 | 0.199 | -0.267 | -0.037 |
| EBIT 1 | -0.0576 | -0.698 | -0.25 | 0.111 | -0.309 | -0.051 |
| Operating Margin | - | -8.64% | -1.53% | 1.09% | -16.33% | -17.06% |
| Earnings before Tax (EBT) 1 | -0.0357 | -0.735 | -0.052 | -12.18 | 0.2 | -0.068 |
| Net income 1 | -0.0381 | -0.735 | -0.052 | -12.18 | 0.201 | -0.066 |
| Net margin | - | -9.09% | -0.32% | -119.37% | 10.62% | -22.07% |
| EPS 2 | -0.000374 | -0.007228 | -0.000511 | -0.1198 | 0.001976 | -0.000649 |
| Free Cash Flow 1 | -0.0878 | 0.922 | -0.8475 | 0.00025 | -1.034 | -0.0254 |
| FCF margin | - | 11.41% | -5.19% | 0% | -54.65% | -8.49% |
| FCF Conversion (EBITDA) | - | - | - | 0.13% | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/21/18 | 3/21/19 | 3/20/20 | 3/19/21 | 3/21/22 | 3/20/23 |
1PLN in Million2PLN
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 0.31 | 0.56 | 0.19 | 0.61 | 0.23 | 0.32 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -0.09 | 0.92 | -0.85 | 0 | -1.03 | -0.03 |
| ROE (net income / shareholders' equity) | -0.29% | -5.79% | -0.42% | -197% | 106% | -25.6% |
| ROA (Net income/ Total Assets) | -0.27% | -2.99% | -0.97% | 0.71% | -8.07% | -2.84% |
| Assets 1 | 13.99 | 24.56 | 5.363 | -1,726 | -2.49 | 2.323 |
| Book Value Per Share 2 | 0.1300 | 0.1200 | 0.1200 | 0 | 0 | 0 |
| Cash Flow per Share 2 | 0 | 0.0100 | 0 | 0 | 0 | 0 |
| Capex | - | 0.3 | 0.16 | 0.26 | - | 0.06 |
| Capex / Sales | - | 3.65% | 0.95% | 2.51% | - | 20.07% |
| Announcement Date | 3/21/18 | 3/21/19 | 3/20/20 | 3/19/21 | 3/21/22 | 3/20/23 |
1PLN in Million2PLN
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 3.5M | |
| +21.69% | 1.61B | |
| +9.10% | 1.21B | |
| -6.42% | 851M | |
| +42.62% | 337M | |
| -36.39% | 295M | |
| +49.39% | 258M | |
| +25.19% | 222M | |
| -9.22% | 84.57M | |
| +32.28% | 64M |
- Stock Market
- Equities
- BER Stock
- Financials Bioerg Spólka Akcyjna
